Company: ARMP
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001104659-25-040273
Chunk: 23

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 23
---
 officer and principal financial officer attend meetings of these committees when they are not in executive session, and often report on matters that may not be otherwise addressed at these meetings. In addition, our directors are encouraged to communicate directly with members of management regarding matters of interest, including matters related to risk, at times when meetings are not being held. Meetings of the Board of Directors During 2024, our Board of Directors met five times, the Audit Committee met four times, the Compensation Committee met one time, the Nominating and Corporate Governance Committee met one time, and the Special Committee met five times. Each Board member attended 75% or more of the total number of meetings of the Board and of the committees on which he or she served, that were held during the portion of the last fiscal year for which he or she was a director or committee member. As required under applicable NYSE American exchange listing standards, during 2024, our independent directors met on a regular basis in executive session without the presence of non-independent directors and management. Each director is expected to devote the time necessary to appropriately discharge his or her responsibilities and to rigorously prepare for and attend and participate in all Board meetings and meetings of Board committees on which he or she serves. In addition, the independent directors meet regularly in executive session without the presence of management. 13

Policy Concerning Director Attendance at Annual Meetings of Shareholders There is no formal policy as to their attendance at annual meetings of shareholders, and in the past our directors have not been present for such meetings. Information Regarding Committees of the Board of Directors The Board of Directors has an Audit Committee, a Compensation Committee, a Nominating and Corporate Governance Committee and a Special Committee. Each of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee operates under a written charter, the adequacy of which each respective committee regularly reviews and reassesses. A copy of each charter is available under the heading “Corporate Governance” of the Investor Relations section of our website at https://investor.armatapharma.com/corporate-governance. Our Board of Directors may establish additional committees from time to time in accordance with our Bylaws. As of April 17, 2025, the record date, the membership of the standing committees was as follows:

| Name                       | ​ | ​ | Audit |   |    |   | ​ | ​ | Compensation |   |    |   | ​ | ​ | Nominating andCorporate Governance |   |    |   | ​ | ​ |